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Summary  
 
Background: Subtle and inconsistent differences in hypothalamic-pituitary-adrenal (HPA) 
axis activity have been reported for patients with panic disorder. While these patients show 
little or no alterations in basal ACTH and cortisol levels, it has been hypothesized that HPA 
hyperresponsivity was a trait in panic patients when exposed to novel and uncontrollable 
stimulation.  
Methods: Thirty-four patients (23 females, mean age 35 yrs) diagnosed with panic disorder 
were compared to 34 healthy controls matched for age, gender, smoking status, and use of 
oral contraceptives. Both groups were exposed twice to a potent laboratory stress protocol, the 
Trier Social Stress Test (TSST) on consecutive days. Free salivary cortisol levels and heart 
rate responses were repeatedly measured before and following the TSST. In addition, the 
cortisol awakening response (CAR) was assessed to further investigate HPA reactivity in PD 
patients.  
Results: While the TSST induced similar heart rate stress responses in both groups, cortisol 
responses were clearly absent in the panic patients with normal responses in the controls 
(F(1.96, 66) = 20.16; p < 0.001). No differences in basal cortisol levels were observed in the 
extended baseline period. The same cortisol stress non-response patterns were observed when 
patients with/without comorbid depression, or with/without psychotropic medication were 
compared. In contrast to their non-response to the psychosocial stressor, panic patients 
showed a significant CAR.  
Conclusion: These findings provide strong evidence to suggest that PD patients present with a 
striking lack of cortisol responsivity to acute uncontrollable psychosocial stress under 
laboratory conditions. This unresponsiveness of the HPA axis appears to be rather specific, 
since a normal CAR in the morning could be documented in these patients. Thus, the present 
results do not support the hypothesis that PD patients show a trait HPA hyperresponsiveness 
to novel and uncontrollable stimulation. In contrast, the data provide support for a 
hyporesponsive HPA axis under emotional stress in PD patients.   
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1. Introduction  
 
Panic disorder is defined as a clinical condition in which the patients experience recurrent 
episodes of panic attacks and constant concern of future attacks. It is a common disorder with 
significant burden of suffering for the individual and significant economic costs for the 
society, respectively (Greenberg et al., 1999). The disease has been linked to increased 
mortality and cardiovascular disease (Albert et al., 2005; Smoller et al., 2005).  
 
Among a multitude of other bodily systems, considerable research efforts have tried to 
associate panic disorder with an abnormal functioning of the hypothalamic-pituitary-adrenal 
system (HPA). While some reports suggested increased basal cortisol production, blunted 
ACTH and cortisol responses to CRH infusion, along with subtle differences in feedback 
sensitivity of the axis (Roy-Byrne et al., 1986; Holsboer et al., 1987; Gurguis et al., 1991; 
Schreiber et al., 1996; Erhardt et al., 2006; Abelson et al., 2007), findings have remained 
inconsistent throughout the past 20 years. Furthermore, studies of naturally occurring panic 
attacks showed that these attacks occur without an apparent secretory episode of cortisol 
inmost instances (Cameron et al., 1987; Bandelow et al., 2000). This eminent lack of cortisol 
response to a situation often perceived by the patients as life threatening is puzzling, since 
HPA activity is well known to rapidly increase in times of threat or harmful stimulation 
(Mason, 1968). However, most patients studied for acute endocrine responses to panic attacks 
(naturally or in the lab) had experienced dozens of attacks before. Thus, it is tempting to 
speculate that the cortisol non-response to acute panic attacks simply reflects successful 
habituation to repeated stimulation by complex emotional events. In healthy volunteers, rapid 
habituation of cortisol responses can be observed when subjects are repeatedly exposed to 
stressful stimuli in the same environmental context (Kirschbaum et al., 1995; Schommer et 
al., 2003). Habituation of cortisol stress responses under such conditions indicate a decrease 
in novelty, unpredictability, and uncontrollability of the situation.  
 
Summarizing the contradictory and inconsistent findings on HPA abnormalities in patients 
suffering from panic disorder, Abelson et al. (2007) concluded that this disorder is 
characterized by an enhanced sensitivity to novelty with a heightened fear of panic in 
unfamiliar environments. They hypothesized that in response to novel experimental contexts 
panic disorder patients would therefore display an enhanced HPA reactivity. Unfortunately, 
the literature on acute ACTH or cortisol responses to such stimuli involving novel, 
uncontrollable, and threatening experiences is sparse at best. Only three published studies so 
far investigated HPA responses to psychosocial challenge (Leyton et al., 1996; Hoehn et al., 
1997; Garcia-Leal et al., 2005). However, none of the stimulation protocols employed in these 
studies lead to significant cortisol elevations in either, panic patients or control subjects.  
 
In order to test the hypothesis of a heightened HPA responsiveness to novel, uncontrollable, 
and threatening stimuli in panic disorder patients, we used a well-established psychosocial 
stress paradigm, the Trier Social Stress Test (TSST; Kirschbaum et al., 1993). In a recent 
meta analysis, the TSST has been found to be among the most potent manipulations for the 
induction of acute cortisol responses under laboratory conditions (Dickerson and Kemeny, 
2004). With healthy adolescents or adults, the TSST yields an average responder rate of 75—
80% of all subjects tested. Thus, this protocol appeared well suited for an appropriate 
investigation of putative HPA response differences in patients with panic disorder.  
 
2. Materials and methods  
 
2.1. Study participants  
 
Patients with panic disorderwere recruited from January 2006 to July 2007 at the Carl Gustav 
Carus University Hospital of the Technische Universitaet Dresden, Germany. The Structured 
Clinical Interview (SCID, Spitzer et al., 1990; Wittchen et al., 1990) for the Diagnostic and 
StatisticalManual of Mental Disorders (DSM-IV) was used to diagnose of panic disorder with 
or without agoraphobia (APA, 2004), respectively.  
 
Patients with a current primary diagnosis of panic disorder with or without agoraphobia were 
included. A secondary diagnosis of dysthymia or mild depression did not preclude 
participation. Diagnostic exclusion criteria were: Any other mental disorders according to the 
SCID, and any acute and/or chronic medical illness as assessed by a physical examination and 
routine laboratory. In order to avoid a significant selection bias in the recruitment of patients, 
habitual cigarette smoking, use of oral contraceptives, or pharmaceutical treatments of panic 
disorder were allowed. They were carefully matched on these variables with healthy control 
subjects (except for the use of pharmaceutical drug treatment). A total of 47 patients were 
approached. Twelve patients did not meet the inclusion criteria, and one patient dropped out 
during the procedure. Of the 12 patients that did not meet the inclusion criteria, five did not 
fulfill the SCID criteria for panic disorder, five suffered additionally from somatoform 
disorders, one was found to have additionally a post-traumatic stress disorder and one was 
excluded due to drug abuse (Fig. 1).  
 
The final study sample consisted of N = 34 patients with a primary diagnosis of panic 
disorder, 11 patients of whom were diagnosed with a secondary diagnosis of depression. The 
mean age at the onset of panic disorder was 29.00 (SD = 11.09) years of age, and the mean 
duration of the panic disorder was 6.06 (SD = 8.00) years. According to the Panic and 
Agoraphobia-Severity-Scale (PAS) (Bandelow, 1979) most of the panic symptoms were rated 
as severe.  
 
Of the 34 patients, 19 were on various drug treatments at the time of testing [selective 
serotonin reuptake inhibitors (SSRIs; n = 5), serotonin norepinephrine reuptake inhibitors 
(SNRIs; n = 5), tricyclic antidepressants (n = 2), tetracyclic antidepressants (n = 3), buspiron 
(anxiolytic; n = 1), monoamine oxidase inhibitors (MAOIs; n = 1), atypical antidepressants (n 
= 1), phytosedatives (n = 4)].  
 
The healthy controls (n = 34) had been recruited through newspaper advertisements, and were 
matched by age and gender to the patient sample. Out of 67 volunteers, twelve were excluded 
due to a current or life-time major mental disorder revealed by the SCID. From the remaining 
55 volunteers, 34 were selected to provide close matches to the 34 patients with respect to age 
and gender. Characteristics of patients and matching controls are provided in Table 1.  
 
All study participants provided written informed consent. The study protocol was approved by 
the local Ethics Committee of the Medical Faculty of the Technische Universität Dresden, 
Germany (No EK7012006).  
 
2.2. Procedures  
 
The participants were individually scheduled for the TSST sessions on 2 consecutive days (t1, 
t2) between 0300 h and 1800 h in order to minimize the circadian variations in cortisol levels. 
Upon arrival at the laboratory, subjects were fitted a belt for continuous wireless transmission 
of heart rate signals (Polar S810, Polar, Finland). Following a brief baseline period of 25 min, 
the study participants were exposed to the TSST. This psychosocial stress protocol mainly 
consists of a social-evaluative situation including a 5 min public speaking task and a 
subsequent 5 min mental arithmetic task in front of a two-person panel. A detailed description 
and evaluation of the TSST was recently published (Kudielka et al., 2007 — The TSST 
revisited: Ten years of research). The participants were asked to refrain from eating, drinking, 
and smoking for at least 2 h before testing as well as during the one and a half hour testing 
session. Healthy controls and patients were tested in the same setting with identical 
procedures and staff present at each of the two repeated TSST sessions. A total of seven saliva 
samples were collected throughout each of the two TSST-sessions (10 min before, 1, 10, 20, 
30, 40, and 50 min after completion of the TSST). In addition to the TSST, patients collected 
two saliva samples on 2 consecutive weekday mornings immediately at wake-up, and 30 min 
thereafter. Approximately 70—80% of all subjects tested so far show a marked cortisol 
increase of 50—80% half an hour after wake-up. This response has been termed „cortisol 
awakening response“ (CAR; Fries, Dettenborn and Kirschbaum, 2008). Compliance with the 
saliva collection protocol was electronically monitored (MEMs caps, Aardex, Switzerland).  
 
2.3. Saliva collection and cortisol analysis  
 
For quick and hygienic collection of saliva samples Salivette swabs were used (Sarstedt, 
Nümbrecht, Germany). The samples were kept frozen at -20 °C until assay. Before analysis, 
samples were centrifuged at 3000 rpm for 5 min to produce a clear supernatant of low 
viscosity. 50 ml were removed for cortisol analysis using a commercially available 
immunoassay with chemiluminescence detection. The lower detection limit of this assay is 
0.43 nmol/l. Intra- and inter-assay coefficients of variation were below 8% for low (3 nmol/l) 
and high (25 nmol/l) cortisol levels, respectively.  
 
2.4. Psychopathological assessments  
 
In patients, the psychopathological burden and severity of panic-agoraphobia wasmeasured by 
two instruments before the patients’ psychotherapeutic treatment: (1) The Symptom Check 
List (Derogatis, 1977; Franke, 2002) consisting of 90 items with a five-point rating scale 
(total score range 20— 80) for the patient to evaluate his/her own psychological and physical 
impairment. In addition, (2) the Panic and Agoraphobia Severity Scale (Bandelow, 1979) was 
used to assess the specific symptom severity for anxiety and phobic anxiety. This self-rating 
questionnaire consists of 13 items rated on a five-point rating scale (total score range: 0—52). 
The depressive symptoms were evaluated by (3) the Beck Depression Inventory (BDI) (Beck 
et al., 1961; Hautzinger et al., 1994). The BDI consists of 21 symptoms and attitudes which 
are rated in terms of intensity from 0 to 3 (total score range: 0—63).  
 
2.5. Statistical analysis  
 
Analyses of variance (ANOVAs) for repeated measures were performed to reveal possible 
main or interaction effects in cortisol and heart rate responses to the TSST for panic patients 
and healthy control subjects. Greenhouse-Geisser correction was applied to account for 
violation of the sphericity assumption. A response to the TSST was defined as an increase in 
cortisol levels of 2.5 nmol/l over the baseline (Van Cauter and Refetoff, 1985). Main effects 
of smoking, use of oral contraceptive medication, and psychotropic drugs were tested by 
univariate ANOVAs. The CAR on the two consecutive mornings was tested for statistical 
significance by ANOVA for repeated measures. Data analyses were performed using SPSS v. 
12 (SPSS Inc., Chicago, IL, USA).  
 
3. Results  
 
There were no significant differences in baseline cortisol levels between panic disorder 
patients and healthy controls before either of the two TSST sessions (both F < 1). Also, 
baseline levels were not influenced by smoking status, use of contraceptive pills, or 
psychotropic medication status, respectively (all p < .01). While TSST exposure lead to the 
well-documented increase in cortisol levels in healthy controls (responder rates: 82% t1; 59% 
t2), PD patients failed to show a significant elevation of cortisol levels on either test day 
(responder rates: 8.8% t1; 2.9% t2; chi-square tests for responder rates in both groups: t1: 
Chi2 = 19.33, df = 1, p < .001; t2: Chi2 = 12.21, df = 1, p < .001); see Fig. 2(a)— (b)). 
ANOVA results indicated significant main group effect (F(1.66) = 8.56; p < .001) as well as a 
significant group by time interaction effect for both test days (F1.95, 66 = 12.67; p < .001). 
While healthy controls showed a small habituation effect with lower cortisol responses upon 
the second stress exposure (F2.33,33 = 12.13; p < .001), no differences in cortisol patterns 
were observed in the patient group across days (F < 1). Within the group of PD patients, 
neither a secondary diagnosis of depression, nor use of psychotropic medication showed an 
impact on the cortisol patterns (all F < 1; see Fig. 2(c) and (d)). Likewise, neither smoking nor 
use of oral contraceptives had an impact on the cortisol response pattern in the PD patients. 
Separate analyses with either only nonsmokers, or women without oral contraceptives 
revealed the same result. No significant cortisol responses were observed in these subgroups 
of patients either (Fig. 2c, d).  
 
While the PD patients did not respond with elevated cortisol levels in response to the 
psychosocial stress test, they displayed a significant rise of cortisol levels after awakening on 
both days tested (F1,28 = 16.13, p < .001) with no significant difference in CAR magnitude 
between the two consecutive mornings (F1,28 < 0.01, p = .97). In contrast to the cortisol 
response patterns, heart rate responses did not differ between PD patients and controls (Fig. 
3). Significant heart rate increases were observed in both groups for both TSST sessions with 
no response attenuation to the second TSST exposure (F2.82,66 = 1.75; p = .17).  
 
4. Discussion  
 
This is the first report of a striking cortisol non-response to moderate or intense psychosocial 
stress in a group of patients with panic disorder. Although such a hypo/non-response pattern 
had been suggested by other studies in the past (Leyton et al., 1996; Hoehn et al., 1997; 
Garcia-Leal et al., 2005), these experiments yielded inconclusive data due to stress protocols 
that did not lead to HPA activation in the control subjects either. In the present work, we 
employed a well-established potent laboratory stress protocol, the TSST, for significant 
activation of the HPA axis. As expected, control subjects showed a typical TSST-induced rise 
in cortisol levels with a peak 10 min following stress cessation. With some 80% of controls 
showing a rise of at least 2.5 nmol/l in response to the TSST, also the percentage of cortisol 
stress responders was in the typical range (Kirschbaum, Pirke and Hellhammer, 1993). In 
contrast to these individuals, less than 10% PD patients showed a cortisol rise indicative of a 
secretory episode to the first TSST, while only a single PD patient had a cortisol response to 
the second TSST. With an experience of more than 15 years of stress research with the TSST, 
this laboratory has never before observed such a uniform pattern of cortisol non-
responsiveness in any group of subjects or patients investigated. Moreover, the TSST 
nonresponsiveness with regard to free cortisol levels cannot be explained by the use of 
psychotropic medication, nor with comorbid depression. In fact, if any, only those PD patients 
with comorbid depression tended to show a small (not statistically significant) elevation of 
cortisol levels. Likewise, the use of oral contraceptives or habitual cigarette smoking does not 
differentiate between the two groups of adults tested here either. In the controls, similar 
numbers of subjects smoked and/or used oral contraceptives. Despite a trend towards lower 
responses, these subjects clearly responded to the TSST. This was not the case in the group of 
PD patients.  
 
Our results suggest a rather specific failure to mount a significant cortisol response to ego-
threatening, uncontrollable psychosocial stress in PD, since the patients showed a completely 
normal cortisol rise 30 min after waking up in the morning (CAR). As suggested by previous 
work, the CAR correlates well with the adrenal capacity to respond to ACTH stimulation, but 
not with the individual TSST response (Schmidt-Reinwald et al., 1999). Thus, in principal the 
adrenal cortex of PD patients appears to be responsive to ACTH, however, there is a clear 
lack of CRH or ACTH signaling to the adrenal cortex in response to distressing psychosocial 
stimulation. The present data therefore contradict conclusions drawn by Abelson et al. (2007) 
that PD patients would show an enhanced HPA responsiveness to novel and uncontrollable 
situations.  
 
Where does this apparent stress non-responsiveness come from? One might speculate that the 
current findings could suggest that PD patients respond to ego-threatening uncontrollable 
stress with dissociation. While this appears to be an attractive speculation, the heart rate 
responses of our patients are clearly indicative that they actively and consciously participated 
in the TSST tasks.  
 
Alternatively, one may think of habituation as a proper explanation for the cortisol non-
response pattern observed here. Most patients with panic disorder are prone to experience a 
large number of panic attacks over the course of years. It could be argued, that consistent with 
McEwen’s pattern of „repeated hits“ in his allostatic load model (1998), these patients 
develop such non-responsiveness over time. The many instances that the patients experience a 
situation, which they perceive as life threatening, might be related to an absent HPA response 
to a ‘minor’ stressor like the TSST. Following this line of reasoning, we have begun to 
investigate newly diagnosed PD patients who have had one or two panic attacks only. None of 
these patients mounted a cortisol response to the TSST either (data not shown). In addition, 
successful psychotherapy (with or without psychotropic medication) did not appear to reverse 
the pattern of cortisol nonresponsiveness to the TSST in our patients (data not shown). 
Although inconclusive for now (due to a small number of patients studied so far), the present 
observations in PD patients speak for a characteristic trait. An exciting hypothesis might thus 
be to speculate that a pattern of HPA (or cortisol) non-responsiveness to psychosocial stress 
represents a vulnerability factor for a later development of PD. Either causally or just 
correlationally related, such risk factor might be associated with a specific genotype pattern 
(Smoller et al., 2008). Genetic polymorphisms that are associated with an increased 
processing of emotional stimuli in the prefrontal cortex, such as the COMT val158met 
polymorphism (Domschke et al., 2008), might be involved in the downregulation of the HPA 
response to stressful stimuli. Such inverse correlation between activity in the prefrontal cortex 
and cortisol response to psychosocial stress has been documented in functional imaging 
studies recently (Wang et al., 2005; Kern et al., 2008). To what extent this apparent cortisol 
non-responsiveness to psychosocial stress is linked to the increased mortality and 
cardiovascular disease observed in these patients (Albert et al., 2005; Smoller et al., 2005), 
remains to be elucidated.  
 
While the present results may unveil an interesting psychoneuroendocrine feature of PD 
patients, our findings need to be replicated in a study with concurrent saliva and blood 
samples. The present work was performed only with salivary cortisol measures — which 
might be the relevant fraction of cortisol to reach the target tissues, including the brain 
(Hellhammer et al., 2009). However, additional ACTH and total cortisol measures would 
describe in more detail to what extent and at which level the HPA axis is disturbed or 
dysfunctional in PD patients.  
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